Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

IMW 2019 | Important genomic factors for SM progression

Brian Walker • 13 Sep 2019
IMW 2019
Multiple Myeloma

Brian Walker, PhD, University of Arkansas for Medical Sciences, Little Rock, AR, speaking from the International Myeloma Workshop (IMW) 2019, held in Boston, MA, discusses the primary genomic factors that contribute to the progression of smoldering myeloma (SM).

More from Brian Walker

The future of myeloma therapy
The future of myeloma therapy
Brian Walker • 15 Apr 2023
An update on the genomic landscape of MM
2:00
An update on the genomic landscape of MM
Brian Walker • 15 Sep 2019
Non-coding mutations impact gene expression in myeloma
0:42
Non-coding mutations impact gene expression in myeloma
Brian Walker • 13 Sep 2019
Re-evaluating the role of epigenetics in multiple myeloma
12:00
Re-evaluating the role of epigenetics in multiple myeloma
Brian Walker • 18 Oct 2017

Related Videos

Updated results from the iMMagine-1 trial of anito-cel in R/R multiple myeloma
4:32
Updated results from the iMMagine-1 trial of anito-cel in R/R multiple myeloma
Brian Walker • 18 Dec 2025
Investigating AZD0120, a dual-targeting CAR-T product, in R/R myeloma: DURGA-1 preliminary results
3:36
Investigating AZD0120, a dual-targeting CAR-T product, in R/R myeloma: DURGA-1 preliminary results
Brian Walker • 7 Dec 2025
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
3:11
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
Brian Walker • 7 Dec 2025
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
4:04
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
Brian Walker • 15 Dec 2025
The content of VJHemOnc is intended for healthcare professionals